ExploreInterventionPositive screening for depression on PHQ-9 (Patient Health Questionnaire 9)
Intervention

Positive screening for depression on PHQ-9 (Patient Health Questionnaire 9)

Also known as: Positive screening for depression on PHQ-9 Positive screening for depression on PHQ-9 (Patient Health Questionnaire 9) Positive screening for depression on Patient Health Questionnaire 9 Positive screening for depression on Patient Health Questionnaire 9 (finding) Screening for depression concern among people who inject opioids at syringe services programs to identify individuals interested in reducing opioid use PHQ-9 ON
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22
None
improvement

Among PWID whose main drug was an opioid, concern about depression was associated with three times the odds of interest in reducing or stopping opioid use (AOR 3.04, 95% CI 1.48-6.22, p = .002) after

Effect: improvement; AOR 3.04; CI: 95% CI: 1.48-6.22

Size: AOR 3.04 CI: 95% CI: 1.48-6.22

Papers (1)